News (42)

Update
DateNews
Feb 23, 2017Xconomy - Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO
Jan 26, 2017Business Wire - Celgene Reports Fourth Quarter and Full-Year 2016 Operating and Financial Results
Aug 20, 2016SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Aug 20, 2016SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
May 3, 2016PRNewswire Asia - WuXi Healthcare Ventures Appoints Renowned Life Science Entrepreneur, Gregory Verdine, Ph.D. as newest Venture Partner
Apr 13, 2016Xconomy - With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets
Jul 23, 2015Business Wire - Celgene Reports Second Quarter 2015 Operating and Financial Results
Jul 14, 2015Business Wire - Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Apr 30, 2015Business Wire - Celgene Reports First Quarter 2015 Operating and Financial Results
Apr 30, 2015Business Wire - Celgene Reports First Quarter 2015 Operating and Financial Results
Mar 4, 2015Xconomy - Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles
Mar 4, 2014SEC - SEC FORM D
Mar 3, 2014SEC - SEC FORM D
Feb 6, 2014SEC - SEC FORM D
Jul 29, 2013Xconomy - Celgene Nabs Option to Buy Acetylon for More Than $1.7B
Jul 2, 2013Xconomy - Harvard Professor Steps Down to Pilot Warp Drive Bio
Dec 7, 2010Xconomy - Why It’s Noble to Be An Innovator
May 12, 2010Xconomy - Is the Venture Model Really Broken?
Jan 15, 2010ir.celgene.com - Celgene Completes Acquisition of Gloucester Pharmaceuticals
Dec 7, 2009Xconomy - Celgene Agrees to Acquire Gloucester Pharma for $340M Cash Upfront, $300M Later